Sanofi (SNY) Enterprise Value (2009 - 2026)

Sanofi has disclosed Enterprise Value across 18 years of filings, most recently posting -$6.9 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$6.9 billion, up 24.87% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.9 billion (up 24.87% YoY), and the FY2025 annual result was -$8.3 billion, down 10.1% from the prior year.
• Enterprise Value came in at -$6.9 billion for Q1 2026 at Sanofi, up from -$8.3 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$6.9 billion in Q1 2023 to a low of -$13.8 billion in Q2 2023.
• The 5-year median for Enterprise Value is -$8.8 billion (2023), against an average of -$9.3 billion.
• Peak annual rise in Enterprise Value reached 38.34% in 2023, while the deepest fall reached 29.12% in 2023.
• Sanofi's Enterprise Value stood at -$12.6 billion in 2022, then gained by 28.4% to -$9.0 billion in 2023, then gained by 16.13% to -$7.6 billion in 2024, then fell by 10.1% to -$8.3 billion in 2025, then rose by 16.91% to -$6.9 billion in 2026.
• The last three Enterprise Value figures came in at -$6.9 billion (Q1 2026), -$8.3 billion (Q4 2025), and -$10.4 billion (Q3 2025), per Business Quant data.